ArticleDiscover oncology2023

Chemotherapy following immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: clinical effectiveness and influence of inflammatory and nutritional factors.

Akihiro Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.